ATE366579T1 - Verfahren zur behandlung von leberkrebs durch intrahepatische verabreichung von nemorubicin - Google Patents
Verfahren zur behandlung von leberkrebs durch intrahepatische verabreichung von nemorubicinInfo
- Publication number
- ATE366579T1 ATE366579T1 AT04710040T AT04710040T ATE366579T1 AT E366579 T1 ATE366579 T1 AT E366579T1 AT 04710040 T AT04710040 T AT 04710040T AT 04710040 T AT04710040 T AT 04710040T AT E366579 T1 ATE366579 T1 AT E366579T1
- Authority
- AT
- Austria
- Prior art keywords
- nemorubicin
- liver cancer
- treating liver
- intrahepatic administration
- intrahepatic
- Prior art date
Links
- 201000007270 liver cancer Diseases 0.000 title abstract 2
- 208000014018 liver neoplasm Diseases 0.000 title abstract 2
- CTMCWCONSULRHO-UHQPFXKFSA-N nemorubicin Chemical compound C1CO[C@H](OC)CN1[C@@H]1[C@H](O)[C@H](C)O[C@@H](O[C@@H]2C3=C(O)C=4C(=O)C5=C(OC)C=CC=C5C(=O)C=4C(O)=C3C[C@](O)(C2)C(=O)CO)C1 CTMCWCONSULRHO-UHQPFXKFSA-N 0.000 title abstract 2
- 229950010159 nemorubicin Drugs 0.000 title abstract 2
- 210000001367 artery Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03100470 | 2003-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE366579T1 true ATE366579T1 (de) | 2007-08-15 |
Family
ID=32921607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04710040T ATE366579T1 (de) | 2003-02-26 | 2004-02-11 | Verfahren zur behandlung von leberkrebs durch intrahepatische verabreichung von nemorubicin |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060264388A1 (de) |
| EP (1) | EP1596874B1 (de) |
| JP (1) | JP2006519209A (de) |
| AT (1) | ATE366579T1 (de) |
| DE (1) | DE602004007491T2 (de) |
| ES (1) | ES2289483T3 (de) |
| TW (1) | TW200501967A (de) |
| WO (1) | WO2004075904A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100464783C (zh) * | 2004-11-22 | 2009-03-04 | 山东蓝金生物工程有限公司 | 一种含抗肿瘤抗生素的抗癌药物组合物 |
| ES2552718T3 (es) * | 2007-05-11 | 2015-12-01 | Nerviano Medical Sciences S.R.L. | Composición farmacéutica de una antraciclina |
| CN102026634B (zh) | 2008-04-10 | 2014-01-22 | 弗吉尼亚州立邦联大学 | 诱导肿瘤缺氧以治疗癌症 |
| FR2992863B1 (fr) * | 2012-07-06 | 2014-08-29 | Chu De Dijon | Composition pharmaceutique pour le traitement du cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9820012D0 (en) * | 1998-09-14 | 1998-11-04 | Pharmacia & Upjohn Spa | Use of an anthracycline derivative for the treatment of a liver tumor |
| GB9909925D0 (en) * | 1999-04-29 | 1999-06-30 | Pharmacia & Upjohn Spa | Combined preparations comprising anthracycline derivatives |
-
2004
- 2004-02-11 US US10/546,234 patent/US20060264388A1/en not_active Abandoned
- 2004-02-11 JP JP2006502019A patent/JP2006519209A/ja active Pending
- 2004-02-11 ES ES04710040T patent/ES2289483T3/es not_active Expired - Lifetime
- 2004-02-11 DE DE602004007491T patent/DE602004007491T2/de not_active Expired - Lifetime
- 2004-02-11 WO PCT/EP2004/050112 patent/WO2004075904A1/en not_active Ceased
- 2004-02-11 EP EP04710040A patent/EP1596874B1/de not_active Expired - Lifetime
- 2004-02-11 AT AT04710040T patent/ATE366579T1/de not_active IP Right Cessation
- 2004-02-24 TW TW093104565A patent/TW200501967A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20060264388A1 (en) | 2006-11-23 |
| DE602004007491T2 (de) | 2008-03-13 |
| JP2006519209A (ja) | 2006-08-24 |
| TW200501967A (en) | 2005-01-16 |
| WO2004075904A1 (en) | 2004-09-10 |
| EP1596874A1 (de) | 2005-11-23 |
| EP1596874B1 (de) | 2007-07-11 |
| DE602004007491D1 (de) | 2007-08-23 |
| ES2289483T3 (es) | 2008-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE521357T1 (de) | Verfahren zur behandlung von hepatitis | |
| DE60215787D1 (de) | Behandlung von typ ii diabetes mit dipeptidyl-peptidase-iv-hemmern | |
| NO20053077L (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
| DK1346041T3 (da) | Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom | |
| DE60331537D1 (de) | Kombinationen zur behandlung von multiplem myelom | |
| DE602004028841D1 (de) | Purin nucleoside für die behandlung von durch flavividrae verursachten krankheiten, einschliesslich hepatitis c | |
| ATE450265T1 (de) | Pharmazeutische mischung zur behandlung von krebs,die dioxolan nukleosidanalogen enthält | |
| DE60324427D1 (de) | Verfahren zur modulation der tubulindeacetylase-aktivität | |
| CY1111263T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει sns-595 και χρησεις αυτης | |
| ATE516819T1 (de) | Verfahren zur behandlung von b-zell-bedingtem krebs | |
| WO2004006842A3 (en) | Combinations of drugs for the treatment of neoplasms | |
| IS6558A (is) | Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni | |
| EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
| ATE412646T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
| ATE489105T1 (de) | Faktor ixa zur behandlung von blutungsstörungen | |
| DE602004002394D1 (de) | (3-ä3-'(2,4-BIS-TRIFLUORMETHYL-BENZYL)-(5-ETHYL-PYRIMIDIN-2-YL)-AMINOÜ-PROPOXYü-PHENYL)-ESSIGSÄURE UND VERWANDTE VERBINDUNGEN ALS MODULATOREN VON PPARS UND VERFAHREN ZUR BEHANDLUNG VON STOFFWECHSELSTÖRUNGEN | |
| ATE353645T1 (de) | Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia | |
| ATE439833T1 (de) | Pharmazeutische zubereitung enthaltend ein catechin, ascorbinsäure, prolin und lysin zur behandlung von neoplastischen krankheiten | |
| ATE353650T1 (de) | Kombinationstherapie zur behandlung von krebs | |
| DE602004024221D1 (de) | Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen | |
| DE602004007491D1 (de) | Verfahren zur behandlung von leberkrebs durch intrahepatische verabreichung von nemorubicin | |
| ATE421882T1 (de) | Schnellösliches azithromycin in einzeldosisform | |
| EA200600989A1 (ru) | Применение габоксадола для лечения бессонницы | |
| CY1105545T1 (el) | Θεραπεια στατινης για ενισχυση της διατηρησης νοητικης λειτουργιας | |
| EP4525870A4 (de) | Verfahren zur behandlung des cushing-syndroms und von lebererkrankungen sowie zur verringerung der lebertoxizität anderer an einen patienten verabreichter arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1596874 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |